117-hr-9321117th Congress

Independent Drug Value Assessment Act

Sponsored By: Representative Speier, Jackie [D-CA-14]

Unknown

Summary

Independent Drug Value Assessment Act This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Speier, Jackie [D-CA-14]

CA • D

Cosponsors

  • Rep. Nadler, Jerrold [D-NY-12]

    NY • D

    Sponsored 11/16/2022

  • Rep. Porter, Katie [D-CA-47]

    CA • D

    Sponsored 11/16/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation